Jeuveau
What is Jeuveau?
Botox has been in use for 30 years to treat eye disorders, muscle spasms, movement disorder and migraines; and was FDA approved for its anti-aging benefits more than 10 years ago. Jeuveau is the first neurotoxin specifically designed for use in aesthetic enhancement. Some are calling it the new Botox!
Jeuveau was FDA approved in February 2019 for the temporary improvement of moderate to severe glabellar lines called the “elevens” which are short, parallel vertical lines between the eyebrows. The active ingredient in Jeuveau is a neuromodulator (neurotoxin) that has a slightly different chemical makeup than Botox. Jeuveau has fewer impurities.
Jeuveau is injected the same as Botox and has a similar safety profile and effectiveness. Onset of effect takes about 2-3 days, and lasts about 3-6months. However, the duration of effect can vary based on individual characteristics.
How does it work?
Jeuveau relaxes the nerves that cause the muscle contractions that result in dynamic wrinkles from chewing, squinting, smiling and frowning. It prevents the creation of new dynamic wrinkles and deepening of existing dynamic wrinkles caused by repetitive facial movements. The effect is a softening and smoothing of dynamic wrinkles and lines.